Looks like we might be stuck in this range until further information released regarding Scoping Study, infrastructure agreements, & CAPEX funding arrangements. IMO you need to be patient with African Iron ore at the moment, the gloss has come off the players in the area and the market wants proof that projects can actually be developed I think. It's a buying opportunity if you think the Scoping Study will be positive and the CAPEX is going to be able to be funded. This means the company will either get into development or being taken out.
The up side is that there hasn't been any substanital holder notices received indicating sell downs, so the major players are still holding.
What are people's thoughts on whether infrastructure agreements need to be locked in with the Government before the Scoping Study is released? I would have thought so, so that the company can use the correct OPEX regarding rail haulage and port useage?
- Forums
- ASX - By Stock
- EQX
- production this year?
EQX
equatorial resources limited
Add to My Watchlist
11.8%
!
19.0¢

production this year?, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
19.0¢ |
Change
0.020(11.8%) |
Mkt cap ! $24.97M |
Open | High | Low | Value | Volume |
18.0¢ | 20.0¢ | 18.0¢ | $74.24K | 408.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 257110 | 15.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.0¢ | 27052 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 257110 | 0.155 |
2 | 400000 | 0.150 |
1 | 100000 | 0.145 |
2 | 110970 | 0.140 |
1 | 9999 | 0.120 |
Price($) | Vol. | No. |
---|---|---|
0.190 | 27052 | 2 |
0.200 | 115000 | 2 |
0.205 | 30000 | 1 |
0.250 | 50000 | 1 |
0.000 | 0 | 0 |
Last trade - 14.37pm 11/08/2025 (20 minute delay) ? |
Featured News
EQX (ASX) Chart |
The Watchlist
WIN
WIN METALS LTD
Steve Norregard, CEO & MD
Steve Norregard
CEO & MD
SPONSORED BY The Market Online